DZ2720A1 - Gène de streptomyces avermitilis commandant le rapport des avermectines b2:b1 et procédé nouveau pour la production d'avermectines. - Google Patents

Gène de streptomyces avermitilis commandant le rapport des avermectines b2:b1 et procédé nouveau pour la production d'avermectines.

Info

Publication number
DZ2720A1
DZ2720A1 DZ990021A DZ990021A DZ2720A1 DZ 2720 A1 DZ2720 A1 DZ 2720A1 DZ 990021 A DZ990021 A DZ 990021A DZ 990021 A DZ990021 A DZ 990021A DZ 2720 A1 DZ2720 A1 DZ 2720A1
Authority
DZ
Algeria
Prior art keywords
avermectins
production
ratio
new process
streptomyces avermitilis
Prior art date
Application number
DZ990021A
Other languages
English (en)
Inventor
Kim Jonelle Stutzman-Engwall
Yoshihiro Katoh
Hamish Alastair Irvine Mcarthur
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DZ2720A1 publication Critical patent/DZ2720A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
DZ990021A 1998-02-13 1999-02-10 Gène de streptomyces avermitilis commandant le rapport des avermectines b2:b1 et procédé nouveau pour la production d'avermectines. DZ2720A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7463698P 1998-02-13 1998-02-13

Publications (1)

Publication Number Publication Date
DZ2720A1 true DZ2720A1 (fr) 2003-09-01

Family

ID=22120706

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ990021A DZ2720A1 (fr) 1998-02-13 1999-02-10 Gène de streptomyces avermitilis commandant le rapport des avermectines b2:b1 et procédé nouveau pour la production d'avermectines.

Country Status (32)

Country Link
EP (1) EP1053335A1 (fr)
JP (2) JP2002503473A (fr)
KR (3) KR20040099389A (fr)
CN (2) CN1521180A (fr)
AP (1) AP9901463A0 (fr)
AR (1) AR018085A1 (fr)
AU (1) AU752343C (fr)
BG (1) BG64911B1 (fr)
BR (1) BR9907893A (fr)
CA (2) CA2521289A1 (fr)
CO (1) CO5070698A1 (fr)
DZ (1) DZ2720A1 (fr)
EA (1) EA003905B1 (fr)
GT (1) GT199900014A (fr)
HN (1) HN1999000008A (fr)
HR (1) HRP20000539A2 (fr)
HU (1) HUP0100784A3 (fr)
IL (2) IL137610A0 (fr)
IS (1) IS5567A (fr)
MA (1) MA24760A1 (fr)
NO (1) NO20004044L (fr)
NZ (2) NZ505676A (fr)
OA (1) OA11449A (fr)
PA (1) PA8467601A1 (fr)
PE (1) PE20000352A1 (fr)
PL (1) PL194270B1 (fr)
SK (1) SK11722000A3 (fr)
TN (1) TNSN99017A1 (fr)
TW (1) TW585910B (fr)
WO (1) WO1999041389A1 (fr)
YU (1) YU50900A (fr)
ZA (1) ZA991138B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9907893A (pt) * 1998-02-13 2000-11-14 Pfizer Prod Inc Gene de streptomyces avermitilis que dirige a proporção de avermectinas b2:b1
US6248579B1 (en) * 1998-02-13 2001-06-19 Pfizer Inc Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
JP3884651B2 (ja) * 1999-08-12 2007-02-21 ファイザー・プロダクツ・インク B2アベルメクチン:b1アベルメクチンの比を指示するストレプトミセス・アベルミティリス遺伝子
US7630836B2 (en) * 2001-05-30 2009-12-08 The Kitasato Institute Polynucleotides
RU2293117C2 (ru) * 2002-02-12 2007-02-10 Пфайзер Продактс Инк. Ген streptomyces avermitilis и его применение для изменения соотношения авермектинов b2:b1
CN107338210B (zh) * 2017-09-05 2021-08-17 天津科技大学 一种阿维链霉菌合成培养基及其发酵液的制备方法
CN111269296B (zh) * 2020-03-06 2021-11-05 山东大学 一种nLsA蛋白及其结构基因和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4429042A (en) * 1978-09-08 1984-01-31 Merck & Co., Inc. Strain of Streptomyces for producing antiparasitic compounds
IN167980B (fr) * 1987-01-23 1991-01-19 Pfizer
ES2054822T3 (es) * 1987-10-23 1994-08-16 Pfizer Procedimiento para la produccion de agliconas de avermectinas y sus cultivos.
JPH0747171B2 (ja) * 1988-09-20 1995-05-24 株式会社東芝 圧延機の設定方法および装置
DE69023036T2 (de) * 1989-03-31 1996-06-13 Merck & Co Inc Klonierung von Streptomyces avermitilis Genen zur Biosynthese von Avermectin und Verfahren zu ihrer Verwendung.
US5252474A (en) * 1989-03-31 1993-10-12 Merck & Co., Inc. Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use
JP2888586B2 (ja) * 1990-03-05 1999-05-10 社団法人北里研究所 エバーメクチンの特定成分を選択生産するための微生物およびその選択的製造法
FI942725A (fi) * 1993-12-16 1995-06-17 Pfizer Haaraketjuista alfaketohappodenydrogenaasikompleksia koodaavia geenejä Streptomyces avermitiliksesta
BR9907893A (pt) * 1998-02-13 2000-11-14 Pfizer Prod Inc Gene de streptomyces avermitilis que dirige a proporção de avermectinas b2:b1

Also Published As

Publication number Publication date
SK11722000A3 (sk) 2001-04-09
IL137610A0 (en) 2001-07-24
KR20040053390A (ko) 2004-06-23
GT199900014A (es) 2000-07-25
IS5567A (is) 2000-07-20
BG64911B1 (bg) 2006-08-31
NZ505676A (en) 2003-02-28
EA003905B1 (ru) 2003-10-30
WO1999041389A1 (fr) 1999-08-19
YU50900A (sh) 2004-03-12
HN1999000008A (es) 1999-10-29
HUP0100784A2 (hu) 2001-06-28
BR9907893A (pt) 2000-11-14
ZA991138B (en) 2000-08-14
TW585910B (en) 2004-05-01
IL183596A0 (fr) 2007-09-20
PL194270B1 (pl) 2007-05-31
CA2521289A1 (fr) 1999-08-19
OA11449A (en) 2003-12-03
AU1887899A (en) 1999-08-30
HUP0100784A3 (en) 2004-10-28
JP2004283174A (ja) 2004-10-14
EA200000758A1 (ru) 2001-04-23
PA8467601A1 (es) 2000-09-29
NO20004044L (no) 2000-10-11
HRP20000539A2 (en) 2001-04-30
KR20010052166A (ko) 2001-06-25
CO5070698A1 (es) 2001-08-28
PL342468A1 (en) 2001-06-04
KR20040099389A (ko) 2004-11-26
CA2320031A1 (fr) 1999-08-19
CN1297485A (zh) 2001-05-30
AU752343C (en) 2005-11-03
EP1053335A1 (fr) 2000-11-22
JP4011036B2 (ja) 2007-11-21
TNSN99017A1 (fr) 2005-11-10
MA24760A1 (fr) 1999-10-01
JP2002503473A (ja) 2002-02-05
NZ518657A (en) 2003-10-31
NO20004044D0 (no) 2000-08-11
AR018085A1 (es) 2001-10-31
AP9901463A0 (en) 1999-03-31
KR100499214B1 (ko) 2005-07-07
CN1521180A (zh) 2004-08-18
PE20000352A1 (es) 2000-05-16
BG104759A (en) 2001-04-30
AU752343B2 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
AU2705600A (en) Process and apparatus for the production of nanofibers
AU2717999A (en) Process for the production of gamma-butyrolactone
AU4631596A (en) Process for the microbiological production of pha-polymers
DZ2720A1 (fr) Gène de streptomyces avermitilis commandant le rapport des avermectines b2:b1 et procédé nouveau pour la production d'avermectines.
AU3546199A (en) Small molecule anticancer compounds and related production process
AU3042500A (en) Improved process for the production of vitamin b12
AU2515399A (en) Process for the production of gamma-butyrolactone
AU1036600A (en) Method for the production of quercetin and isoquercetin derivatives
HU9903073D0 (en) Streptomyces avermitilis regulatory genes for increased avermectin production
AU3330699A (en) Process for the production of microcapsules
AU5160599A (en) Method for the production of n,n'-carbonyl diazoles
HUP0004631A3 (en) Process for the production of avermectin compounds
HU9800369D0 (en) Pellet-based pharmaceutical composition of controlled release with high content of potassium-chloride, and process for it's production
IL147562A0 (en) Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
AU7773700A (en) Method for the production or preparation of 2,6-dichlorotoluol
HUP0202487A3 (en) Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
FR2720406B1 (fr) Composition de microorganismes et procédé pour la production de xylitol.
AU1123200A (en) Stereoselective process for producing antineoplastic agents
AU2002216685A1 (en) Process for the production of diaryl carbonates
AU1432700A (en) Method and arrangement for the continuous production of lignocellulose-containing boards
AU6724696A (en) Improved process for the production of amphotericin-b
AU2001262240A1 (en) Process for the production of 2,2,6-trimethylcyclohexane-1,4-dione
AU1684700A (en) Process for the production of optically active 3,4-dehydroprolines
AU3274099A (en) Process for producing avermectin b1 derivatives
AU1063300A (en) Process for the production of trifluoromethyltropanone cyanohydrin